Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
8 "Genes"
Filter
Filter
Article category
Keywords
Publication year
Authors
Case report
Classical Hodgkin lymphoma following follicular lymphoma: a case report
Bomi Kim
J Yeungnam Med Sci. 2023;40(Suppl):S113-S122.   Published online August 17, 2023
DOI: https://doi.org/10.12701/jyms.2023.00584
  • 1,272 View
  • 97 Download
AbstractAbstract PDF
The simultaneous, composite, or sequential occurrence of follicular lymphoma (FL) and classical Hodgkin lymphoma (HL), both of which originate from germinal center B-cell, is rare. Questions have been raised with regard to the type of tests that pathologists should perform when observing the presence of a “large-cell lymphoma” following an FL and what are the most critical pathological points for diagnosis. Here, we present a case of a classical HL following an FL after administering rituximab-bendamustine (R-Benda) chemotherapy. Furthermore, we also summarized the literature and compared this case with other HLs that followed FLs. A 55-year-old woman was diagnosed with a grade 3A FL of the breast and axillary lymph node masses. She completed six R-Benda chemotherapy cycles for stage IV FL. Twenty-three months after the diagnosis, follow-up image studies showed an increase in the size and number of the lesions. Biopsies of the neck lymph node and liver were performed, and the diagnosis was classical HL. Sequential or composite FL and HL may sometimes develop from the same clone because they share the same genetic alterations, such as B-cell lymphoma (Bcl)-2 or Bcl-6 translocation. When a large-cell lymphoma is found after the treatment of FL, classical HL should be considered a pathological differential diagnosis, and histological, immunohistochemical, or molecular investigations must be considered during the diagnostic process.
Review articles
Ocular adnexal mucosa-associated lymphoid tissue lymphoma: a narrative review
Hyun Uk Chung, Jun Hyuk Son
J Yeungnam Med Sci. 2022;39(1):3-11.   Published online September 15, 2021
DOI: https://doi.org/10.12701/yujm.2021.01263
  • 4,964 View
  • 154 Download
  • 7 Web of Science
  • 6 Crossref
AbstractAbstract PDF
Lymphoma is the most common primary tumor of the orbit, accounting for 55% of all orbital malignancies. When divided into histopathological subtypes, extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) comprises the largest proportion. Clinical manifestations are unspecific, but in patients with slow-growing painless orbital mass, or red conjunctival lesion suggestive of ‘salmon patch’, ocular adnexa lymphoma (OAL) should be suspected. Although the pathogenetic mechanism of ocular adnexal MALT lymphoma (OAML) is not yet fully understood, the relationship between OAML and Chlamydia psittaci has been hypothesized recently, similar to that between gastric MALT lymphoma and Helicobacter pylori. This suggests a new treatment option for OAML; bacterial eradication therapy with systemic antibiotics. Several other treatment methods for OAML have been introduced, but no treatment guidelines have been established yet. In this article, we summarize the current knowledge on the clinical features, pathogenesis, diagnostic methods, therapeutic strategies, and prognosis of OAML.

Citations

Citations to this article as recorded by  
  • Unusual Pediatric Red Eye
    Carson W. Ercanbrack, Jamal O. Azhari, David B. Warner, Maher Abulfaraj, Abdelrahman M. Elhusseiny
    The Journal of Pediatrics.2024; 267: 113924.     CrossRef
  • The Possible Role of Pathogens and Chronic Immune Stimulation in the Development of Diffuse Large B-Cell Lymphoma
    Lajos Gergely, Miklos Udvardy, Arpad Illes
    Biomedicines.2024; 12(3): 648.     CrossRef
  • Radiomics analysis of T1WI and T2WI magnetic resonance images to differentiate between IgG4-related ophthalmic disease and orbital MALT lymphoma
    Yuchao Shao, Yuqing Chen, Sainan Chen, Ruili Wei
    BMC Ophthalmology.2023;[Epub]     CrossRef
  • Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)
    Mohammad Javed Ali
    Progress in Retinal and Eye Research.2023; 96: 101193.     CrossRef
  • The Biology of Ocular Adnexal Marginal Zone Lymphomas
    Patricia Johansson, Anja Eckstein, Ralf Küppers
    Cancers.2022; 14(5): 1264.     CrossRef
  • One Case of Conjunctival MALT Lymphoma and Literature Review
    旭霞 李
    Advances in Clinical Medicine.2022; 12(08): 7586.     CrossRef
Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment
Kyung Mi Jang
Yeungnam Univ J Med. 2020;37(1):13-21.   Published online January 9, 2020
DOI: https://doi.org/10.12701/yujm.2019.00409
  • 13,042 View
  • 359 Download
  • 20 Crossref
AbstractAbstract PDF
Maturity-onset diabetes of the young (MODY) is a clinically heterogeneous group of monogenic disorders characterized by ß-cell dysfunction. MODY accounts for between 2% and 5% of all diabetes cases, and distinguishing it from type 1 or type 2 diabetes is a diagnostic challenge. Recently, MODY-causing mutations have been identified in 14 different genes. Sanger DNA sequencing is the gold standard for identifying the mutations in MODY-related genes, and may facilitate the diagnosis. Despite the lower frequency among diabetes mellitus cases, a correct genetic diagnosis of MODY is important for optimizing treatment strategies. There is a discrepancy in the disease-causing locus between the Asian and Caucasian patients with MODY. Furthermore, the prevalence of the disease in Asian populations remains to be studied. In this review, the current understanding of MODY is summarized and the Asian studies of MODY are discussed in detail.

Citations

Citations to this article as recorded by  
  • Maturity-onset diabetes of the young type 7 (MODY7) and mutation in the Krüppel-like transcription factor 11 (KLF11) gene
    Y Wang, X Ye, X Chen, H Zang, Q Shen, L Chen
    QJM: An International Journal of Medicine.2024; 117(3): 219.     CrossRef
  • Novel gene mutation in maturity-onset diabetes of the young: A case report
    Na Zhang, Hui Zhao, Cui Li, Feng-Zhi Zhang
    World Journal of Clinical Cases.2023; 11(5): 1099.     CrossRef
  • Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study
    Hui-Xuan Wu, Tian-Yao Chu, Junaid Iqbal, Hong-Li Jiang, Long Li, Yan-Xuan Wu, Hou-De Zhou
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(11): 2970.     CrossRef
  • Genetic and Clinical Characterization of Patients with HNF1B-Related MODY in Croatia
    Maja Baretić, Domagoj Caban, Jadranka Sertić
    Journal of Personalized Medicine.2023; 13(7): 1063.     CrossRef
  • Quantitative profiling and diagnostic potential of one-carbon and central metabolism pools in MODY2 and T1DM
    Jieying Liu, Ziyan Xie, Junling Fu, Miao Yu, Tong Wang, Cuijuan Qi, Peng Liu, Xiangyi Hui, Dongmei Wang, Lu Ding, Qian Zhang, Ting Xie, Xinhua Xiao
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
    Özlem Üstay, Tugçe Apaydın, Onur Elbasan, Hamza Polat, Gizem Günhan, Ceyda Dinçer, Lamia Şeker, Esra Arslan Ateş, Ayşegül Yabacı, Ahmet lter Güney, Dilek Gogas Yavuz
    Archives of Endocrinology and Metabolism.2022;[Epub]     CrossRef
  • Meta-analysis of HNF1A-MODY3 variants among human population
    Rachna Behl, Nishtha Malhotra, Vinay Joshi, Shruti Poojary, Sanniya Middha, Shalini Gupta, Arinola B. Olaonipekun, Ikechukwu Okoye, Bhushan Wagh, Dibyendu Biswas, Chukwuemelie Aginah, Bhavya Saini, Chinaza Nwanya, Sopuluchukwu Ugwu, Modupe M. Anthony, Xua
    Journal of Diabetes & Metabolic Disorders.2022; 21(1): 1037.     CrossRef
  • Unusual manifestations of young woman with MODY5 based on 17q12 recurrent deletion syndrome
    Ying Cheng, Da-Peng Zhong, Li Ren, Hang Yang, Chen-Fu Tian
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Diagnosis and Treatment of Monogenic Forms of Diabetes Mellitus: Focus on Mody-Diabetes
    K. A. Aitbaev, I. T. Murkamilov, Zh. A. Murkamilova, V. V. Fomin, I. O Kudaibergenova, F. A. Yusupov
    The Russian Archives of Internal Medicine.2022; 12(6): 430.     CrossRef
  • Monogenic diabetes: recent updates on diagnosis and precision treatment: A narrative review
    Kyung Mi Jang
    Precision and Future Medicine.2022; 6(4): 209.     CrossRef
  • Modeling Maturity Onset Diabetes of the Young in Pluripotent Stem Cells: Challenges and Achievements
    Carmel Braverman-Gross, Nissim Benvenisty
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Gençlerin Erişkin Başlangıçlı Diyabeti (MODY) Sorumlu HNF4A, GCK ve HNF1 Gen Varyasyonlarının Dünya Genelinde Coğrafik Dağılımı
    Deniz KANCA DEMİRCİ, Nurdan GÜL, İlhan SATMAN, Oguz OZTURK, Hülya YILMAZ AYDOĞAN
    Haliç Üniversitesi Fen Bilimleri Dergisi.2021; 4(1): 41.     CrossRef
  • ABCC8 variants in MODY12: Review of the literature and report of a case with severe complications
    Marijke Timmers, Eveline Dirinck, Patrick Lauwers, Wim Wuyts, Christophe De Block
    Diabetes/Metabolism Research and Reviews.2021;[Epub]     CrossRef
  • Monogenic Childhood Diabetes: Dissecting Clinical Heterogeneity by Next-Generation Sequencing in Maturity-Onset Diabetes of the Young
    Deniz Kanca Demirci, Feyza Darendeliler, Sukran Poyrazoglu, Asli Derya Kardelen Al, Nurdan Gul, Yildiz Tutuncu, Gizem Gulfidan, Kazim Yalcin Arga, Canan Cacina, Oguz Ozturk, Hulya Yilmaz Aydogan, Ilhan Satman
    OMICS: A Journal of Integrative Biology.2021; 25(7): 431.     CrossRef
  • A Comprehensive Analysis of Hungarian MODY Patients—Part II: Glucokinase MODY Is the Most Prevalent Subtype Responsible for about 70% of Confirmed Cases
    Zsolt Gaál, Zsuzsanna Szűcs, Irén Kántor, Andrea Luczay, Péter Tóth-Heyn, Orsolya Benn, Enikő Felszeghy, Zsuzsanna Karádi, László Madar, István Balogh
    Life.2021; 11(8): 771.     CrossRef
  • A Comprehensive Analysis of Hungarian MODY Patients—Part I: Gene Panel Sequencing Reveals Pathogenic Mutations in HNF1A, HNF1B, HNF4A, ABCC8 and INS Genes
    Zsolt Gaál, Zsuzsanna Szűcs, Irén Kántor, Andrea Luczay, Péter Tóth-Heyn, Orsolya Benn, Enikő Felszeghy, Zsuzsanna Karádi, László Madar, István Balogh
    Life.2021; 11(8): 755.     CrossRef
  • Diagnosis and Treatment of MODY: An Updated Mini Review
    Abegail Tshivhase, Tandi Matsha, Shanel Raghubeer
    Applied Sciences.2021; 11(20): 9436.     CrossRef
  • Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research
    Ming Hu, Ines Cherkaoui, Shivani Misra, Guy A. Rutter
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Update on Monogenic Diabetes in Korea
    Ye Seul Yang, Soo Heon Kwak, Kyong Soo Park
    Diabetes & Metabolism Journal.2020; 44(5): 627.     CrossRef
  • The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY)
    Ken Munene Nkonge, Dennis Karani Nkonge, Teresa Njeri Nkonge
    Clinical Diabetes and Endocrinology.2020;[Epub]     CrossRef
Case Report
A Case of Swyer Syndrome
Soon Il Jung, Hee Soon Cho, Chae Hoon Lee, Kyung Dong Kim
Yeungnam Univ J Med. 2007;24(2 Suppl):S665-670.   Published online December 31, 2007
DOI: https://doi.org/10.12701/yujm.2007.24.2S.S665
  • 1,524 View
  • 3 Download
AbstractAbstract PDF
46,XY pure gonadal dysgenesis is a sex-reversal disorder, that is characterized by the presence of a female phenotype, with a normal to tall stature, primary amenorrhea and sexual infantilism. The internal genitalia are female with a uterus and vagina being present, however, there are bilateral dysgenetic gonads. In addition, neoplasia occurs in 20∼30% of patients who have gonadal dysgenesis and a Y chromosome. A 34 year old woman presented to our hospital with the chief complaint of primary amenorrhea. Physical examination revealed no secondary sexual characteristics and no somatic abnormality. Peripheral blood karyotype was 46,XY, and polymerase chain reaction (PCR) for the Sex determining Region Y (SRY) gene was positive. Sequencing analysis of the SRY gene revealed a single nucleotide polymorphism. A laparoscopic gonadectomy was performed to remove both gonads, and no tumor cells were observed. Estrogen replacement therapy was instituted.
Review Article
Clinical Update: Inflammatory Bowel Disease
Byung Ik Jang
Yeungnam Univ J Med. 2007;24(2 Suppl):S221-233.   Published online December 31, 2007
DOI: https://doi.org/10.12701/yujm.2007.24.2S.S221
  • 1,270 View
  • 3 Download
  • 1 Crossref
AbstractAbstract PDF
Inflammatory bowel disease(IBD) which is well known as Crohn’s disease and ulcerative colitis is a chronic disorder that repeats improvement and exacerbation. The possible causes of the disease are environmental factors, genetic factors and immune deficiency resulted from bacterial infection. Recently, IL-23 is proved to be a main cytokine which has a central role in Crohn’s disease. The diagnosis of IBD is made by clinical manifestation, serologic test, endoscopic finding and histologic finding. The mainstay of remission and maintenance therapy of ulcerative colitis is 5-aminosalicylate(5-ASA). Steroid can be used in severe or refractory case and nowadays, budesonide shows a good effect with minimal side effects. In cases of steroid dependent, we can use the immunomodulators such as azathioprine, cyclosporin and 6-thioguanine. The cytokine associated with inflammation of IBD has been emphasized and the treatment which targets the cytokine such as tumor necrosis factor is tried. Infliximab and adalimumab block tumor necrosis factors-a and they are proved the efficacy by many clinical trial. Leukocytapheresis(LCAP) is tried in ulcerative colitis since 1980 in Japan. When we treat IBD patients, we need to consider all the things such as safety, side effects and economy of the patients. We expect that the development of new biologic agent which is more cost effective and more effect with more convinience.

Citations

Citations to this article as recorded by  
  • Inflammatory Bowel Disease and Cytokine
    Eun Young Choi, Kwang Keun Cho, In Soon Choi
    Journal of Life Science.2013; 23(3): 448.     CrossRef
Review
Hirschsprung's Disease.
Nam Hyuk Lee
Yeungnam Univ J Med. 2007;24(1):11-23.   Published online June 30, 2007
DOI: https://doi.org/10.12701/yujm.2007.24.1.11
  • 1,486 View
  • 3 Download
AbstractAbstract PDF
Hirschsprung's disease is one of the most common causes of intestinal obstruction in neonates and infants. The underlying pathology of this disease is the absence of the ganglion cells in both the myenteric (Auerbach's) plexus and the submucosal (Meissner's) plexus. Since Hirschsprung's report in 1886, there have been thousands of papers on Hirschsprung's disease but the cause of the absence of the ganglion cells has not been identified. Hirschsprung's disease can be successfully treated with the Swenson, the Duhamel, and the Soave operations even though the pathogenesis is unknown. With the recent progress of molecular biology and genetics, a more detailed approach to the pathogenesis of Hirschsprung's disease can be undertaken. In addition, there have been recent developments in the surgical approach. In this review, recent advances in surgery for Hirschsprung's disease are presented.
Case Reports
A Case of Constitutional Trisomy 8 Mosaicism.
Hee Soon Cho, Chae Hoon Lee, Kyoung Dong Kim, Eun Sil Lee
Yeungnam Univ J Med. 2005;22(2):241-246.   Published online December 31, 2005
DOI: https://doi.org/10.12701/yujm.2005.22.2.241
  • 1,787 View
  • 5 Download
  • 1 Crossref
AbstractAbstract PDF
Constitutional trisomy 8 is a relatively rare aneuploidy; most identified cases are mosaic with a normal cell line. The phenotype is highly variable from apparently normal to severe disability. The proportion of abnormal cells is dramatically different between tissues and the severity of the phenotype is not directly related to the level of mosaicism. Therefore, it is very difficult to provide a definitive prognosis. We report here a case of constitutional trisomy 8 mosaicism with agenesis of the corpus callosum, congenital heart disease and micrognathia. The trisomy 8 cell line was not detected by prenatal cytogenetic study. This is the fourth reported case of constitutional trisomy 8 mosaicism in Korea.

Citations

Citations to this article as recorded by  
  • A Case of Trisomy 8 Mosaicism in a Patient with Secondary Amnorreha without Abnormal Phenotype
    Hye Sim Kang, Young Soo Son, Sung Yob Kim, Chul Min Park, Soon Sup Shim
    Journal of Genetic Medicine.2011; 8(1): 67.     CrossRef
A Case of Secondary Glaucoma combined with Mesodermal Dysgenesis of Anterior Segment.
Tae Kwang Ahn, Young Hoon Park, Duk Kee Hahn
Yeungnam Univ J Med. 1990;7(1):187-190.   Published online June 30, 1990
DOI: https://doi.org/10.12701/yujm.1990.7.1.187
  • 1,351 View
  • 5 Download
AbstractAbstract PDF
The authors experienced a case of secondary glaucoma combined with mesodermal dysgenesis of anterior segment, which disclosed extensive peripheral iridocorneal adhesion of congenital origin while his fellow eye revealed a sclerocornea. This case is extremely rare and entirely different from the previously reported Axenfeld's and Rieger's anomalies. We report this interesting case with brief review of the literatures.

JYMS : Journal of Yeungnam Medical Science